Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
28.14
-0.19 (-0.67%)
At close: Jul 19, 2024, 4:00 PM
28.35
+0.21 (0.75%)
Pre-market: Jul 22, 2024, 7:28 AM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $12.72 billion as of July 22, 2024. Its market cap has decreased by -31.27% in one year.
Market Cap
12.72B
Enterprise Value
17.33B
1-Year Change
-31.27%
Ranking
Category
Stock Price
$28.14
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from $26.49B to $12.72B, a decrease of -51.98%. That is a compound annual growth rate of -16.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 16.81B | 0.18% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revvity | 13.34B |
| Medpace Holdings | 13.05B |
| Tenet Healthcare | 13.02B |
| Natera | 13.01B |
| Dr. Reddy's Laboratories | 13.01B |
| Smith & Nephew | 12.33B |
| Insmed | 12.25B |
| DaVita | 12.10B |